445 related articles for article (PubMed ID: 23795222)
1. Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health.
Bell IR; Schwartz GE; Boyer NN; Koithan M; Brooks AJ
Eur J Integr Med; 2013 Apr; 5(2):126-140. PubMed ID: 23795222
[TBL] [Abstract][Full Text] [Related]
2. Adaptive network nanomedicine: an integrated model for homeopathic medicine.
Bell IR; Schwartz GE
Front Biosci (Schol Ed); 2013 Jan; 5(2):685-708. PubMed ID: 23277079
[TBL] [Abstract][Full Text] [Related]
3. The Complexity of the Homeopathic Healing Response Part 2: The Role of the Homeopathic Simillimum as a Complex System in Initiating Recovery from Disease.
Bell IR
Homeopathy; 2020 May; 109(2):51-64. PubMed ID: 31785597
[TBL] [Abstract][Full Text] [Related]
4. Low Doses of Traditional Nanophytomedicines for Clinical Treatment: Manufacturing Processes and Nonlinear Response Patterns.
Bell IR; Sarter B; Standish LJ; Banerji P; Banerji P
J Nanosci Nanotechnol; 2015 Jun; 15(6):4021-38. PubMed ID: 26369009
[TBL] [Abstract][Full Text] [Related]
5. Integrative nanomedicine: treating cancer with nanoscale natural products.
Bell IR; Sarter B; Koithan M; Banerji P; Banerji P; Jain S; Ives J
Glob Adv Health Med; 2014 Jan; 3(1):36-53. PubMed ID: 24753994
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of adaptive biological effects by nanotechnology preparation methods in homeopathic medicines.
Bell IR; Schwartz GE
Homeopathy; 2015 Apr; 104(2):123-38. PubMed ID: 25869977
[TBL] [Abstract][Full Text] [Related]
7. A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system.
Bell IR; Koithan M
BMC Complement Altern Med; 2012 Oct; 12():191. PubMed ID: 23088629
[TBL] [Abstract][Full Text] [Related]
8. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.
Hock SC; Ying YM; Wah CL
PDA J Pharm Sci Technol; 2011; 65(2):177-95. PubMed ID: 21502077
[TBL] [Abstract][Full Text] [Related]
9. Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions.
Bell IR; Ives JA; Jonas WB
Dose Response; 2014 May; 12(2):202-32. PubMed ID: 24910581
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Testing the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effects.
Bell IR; Koithan M; Brooks AJ
Homeopathy; 2013 Jan; 102(1):66-81. PubMed ID: 23290882
[TBL] [Abstract][Full Text] [Related]
12. Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children.
Hawke K; King D; van Driel ML; McGuire TM
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD005974. PubMed ID: 36511520
[TBL] [Abstract][Full Text] [Related]
13. Natural product-based nanomedicine: recent advances and issues.
Watkins R; Wu L; Zhang C; Davis RM; Xu B
Int J Nanomedicine; 2015; 10():6055-74. PubMed ID: 26451111
[TBL] [Abstract][Full Text] [Related]
14. Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children.
Hawke K; van Driel ML; Buffington BJ; McGuire TM; King D
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD005974. PubMed ID: 30196554
[TBL] [Abstract][Full Text] [Related]
15. Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children.
Hawke K; van Driel ML; Buffington BJ; McGuire TM; King D
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD005974. PubMed ID: 29630715
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Revia RA; Stephen ZR; Zhang M
Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
[TBL] [Abstract][Full Text] [Related]
18. Emerging Trends in Nanomedicine for Improving Ocular Drug Delivery: Light-Responsive Nanoparticles, Mesoporous Silica Nanoparticles, and Contact Lenses.
Rodrigues FSC; Campos A; Martins J; Ambrósio AF; Campos EJ
ACS Biomater Sci Eng; 2020 Dec; 6(12):6587-6597. PubMed ID: 33320633
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
